Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study

BACKGROUND: Botulinum toxin A (BTX-A) has been used to reduce spasticity in children with cerebral palsy (CP) for decades. The purpose of this study was to analyze to what extent BTX-A treatment was used to treat spasticity in a total population of children with CP. We investigated 1) the use of BTX...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzén, Maria, Hägglund, Gunnar, Alriksson-Schmidt, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725838/
https://www.ncbi.nlm.nih.gov/pubmed/29228927
http://dx.doi.org/10.1186/s12891-017-1880-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725838/
https://www.ncbi.nlm.nih.gov/pubmed/29228927
http://dx.doi.org/10.1186/s12891-017-1880-y

Ejemplares similares